Ose immuno press release
WebJun 23, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebFeb 22, 2024 · OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the online publication in the peer-reviewed ‘The Journal of Immunology’ of positive Phase 1 clinical...
Ose immuno press release
Did you know?
WebFeb 15, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the annual financial report for the fiscal year 2024, available on the OSE Immunotherapeutics’ website. WebApr 4, 2024 · Boehringer Ingelheim and OSE Immunotherapeutics enter into a global license and collaboration agreement in immuno-oncology to develop OSE-172, a novel …
WebSep 22, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebJun 23, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF …
WebJun 6, 2024 · Oslo, Norway, 6 June 2024: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid ... WebMar 30, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF …
WebSep 30, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the...
WebFeb 15, 2024 · OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today provides a regulatory update on the clinical development plan of Tedopi®, an immunotherapy activating tumor... blackwell tribuneWebMar 1, 2024 · OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced that the Spanish Drug Agency (Agencia Espanola de Medicamentos y Productos Sanitarios, AEMPS) has made... blackwell trailer wash pageland scWebApr 5, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Reference Document filed with the AMF on 8 June 2016 under the number R.16-052, the ... fox n the houndWebJul 13, 2024 · NANTES, France, July 13, 2024 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the appointment of Alexis Vandier as Chief Executive Officer, effective immediately. Alexis Vandier brings an impressive track record of successes in Pharma across a range of … blackwell tribune journalWebMar 15, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the... blackwell trainingWebFeb 15, 2024 · Myeloid platform focused on optimizing the therapeutic potential of myeloid cells in IO and immuno-inflammation (I&I). OSE-230 (ChemR23 agonist mAb) ... This … foxnumber6WebMar 15, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … blackwell truck and trailer